Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. (Q53061916)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 March 2014

Language	Label	Description	Also known as
English	Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.	scientific article published on 16 March 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Corinne Faivre-Finn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Giulia Veronesi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

A G Pallis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

C Gridelli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

U Wedding

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M Jaklitsch

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

M O'Brien

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

16 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1270-1283

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638905%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

EORTC elderly task force position paper: approach to the older cancer patient

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Are we treating enough elderly patients with early stage non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Mediastinal lymphadenectomy in elderly patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Reduced lung-cancer mortality with low-dose computed tomographic screening

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Sc

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Cancer screening in elderly patients: a framework for individualized decision making

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Older adults' attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Older adults and forgoing cancer screening: "I think it would be strange".

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Surgical treatment of lung cancer in the octogenarians: results of a nationwide audit

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested case-control study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Progress in Standard of Care Therapy and Modest Survival Benefits in the Treatment of Non-small Cell Lung Cancer Patients in the Netherlands in the Last 20 Years

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Video-assisted thoracic surgery lobectomy: experience with 1,100 cases

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Predictors of nursing home admission, severe functional impairment, or death one year after surgery for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Factors predicting poor survival after resection of stage IA non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Pneumonectomy for non-small cell lung cancer: outcomes analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Postoperative radiotherapy for elderly patients with stage III lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Radiotherapy for lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Weight change in old age and its association with mortality

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the Hoosier Oncology Group: LUN04-77.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy is as effective as for younger patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Non-small cell lung cancer in octogenarians: treatment practices and preferences

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Vulnerability in the elderly: frailty

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Nonreferral of nursing home patients with suspected breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Use of geriatric assessment for older adults in the oncology setting: a systematic review.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Can non-performance of radical systematic mediastinal lymphadenectomy be justified in elderly lung cancer patients? An evaluation using propensity-based survival analysis☆

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU022

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53061916&oldid=2080125596"